Selection of patients for aspirin desensitization treatment

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 4, 2006, Pages 801-804

  Stevenson, Donald D ^a,b   Simon, Ronald A ^a  

^a Asthma and Immunology

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

ASA desensitization; Aspirin; asthma; nasal polyps

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DIPHENHYDRAMINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MONTELUKAST; PREDNISONE; RANITIDINE; ZAFIRLUKAST;

ASPIRIN EXACERBATED RESPIRATORY DISEASE; DESENSITIZATION; DISEASE SEVERITY; EDITORIAL; EPIGASTRIC PAIN; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; EOSINOPHILIA; HUMANS; NASAL POLYPS; PATIENT SELECTION; SINUSITIS;

EID: 33749365192     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.06.019     Document Type: Editorial

References (3)

1. Berges-Gimeno M.P., Simon R.A., and Stevenson D.D. The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 89 (2002) 474-478
2. Berges-Gimeno M.P., Simon R.A., and Stevenson D.D. Long term desensitization with aspirin in AERD. J Allergy Clin Immunol 111 (2003) 180-186
3. White A.A., Stevenson D.D., and Simon R.A. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 95 (2005) 330-335